利用多期CT的快速傅里叶变换分析鉴别实性、非宏观脂肪含量、强化的肾脏肿块
这项回顾性病例对照研究纳入2009年6月至2016年6月间156例实性、非宏观脂肪含量、强化肾脏肿块患者,其中110例(70%)为恶性肾细胞癌(包括透明细胞、乳头状和嫌色细胞亚型),46例(30%)为良性肾脏肿块(嗜酸细胞瘤和乏脂性血管平滑肌脂肪瘤)。研究采用二维快速傅里叶变换(FFT)基于增强CT图像提取肿瘤内纹理变异指标,结果显示FFT指标在良恶性鉴别、嗜酸细胞瘤与透明细胞肾细胞癌鉴别、嗜酸细胞瘤与乏脂性血管平滑肌脂肪瘤鉴别中均有显著差异(p<0.005),受试者工作特征曲线下面积均>0.7(p<0.05)。结论认为FFT指标与其他指标联合可能改善患者管理,并可能有助于鉴别其他肾脏肿瘤。
要点
- FFT指标可鉴别良性与恶性肾脏肿块、嗜酸细胞瘤与透明细胞肾细胞癌、嗜酸细胞瘤与乏脂性血管平滑肌脂肪瘤(p<0.005)。
- 上述三组比较的ROC曲线下面积均>0.7(p<0.05),具有合理的鉴别能力。
- FFT指标与其他指标联合可能改善患者管理,并可能有助于鉴别其他肾脏肿瘤。
核心结论
- FFT-based metrics can differentiate between some solid, non-macroscopic fat containing, enhancing renal masses using their contrast-enhanced CT data; in combination with other metrics, FFT-metrics may improve patient management and potentially help differentiate other renal tumors.
研究设计与样本
- Institutional Review Board approved, Health Insurance Portability and Accountability Act-compliant, retrospective case-control study; 156 patients with predominantly solid, non-macroscopic fat containing, enhancing renal masses identified between June 2009 and June 2016; 110 cases (70%) malignant RCC including clear cell, papillary and chromophobe subtypes, 46 cases (30%) benign renal masses including oncocytoma and lipid-poor angiomyolipoma; whole lesions manually segmented using Synapse 3D (Fujifilm, CT) and co-registered from multiphase CT acquisitions for each tumor; pathological diagnosis of all tumors obtained following surgical resection; Matlab function FFT2 used to perform image to frequency transformation.
诊断标准与关键数值
- Wilcoxon rank sum test showed FFT-based metrics were significantly (p < 0.005) different between 1. benign vs malignant renal masses, 2. oncocytoma vs clear cell renal cell carcinoma and 3. oncocytoma vs lipid-poor angiomyolipoma; receiver operator characteristics analysis revealed reasonable discrimination (area under the curve >0.7, p < 0.05) within these three groups of comparisons.
临床应用与阅片要点
- 作者认为FFT指标与其他指标联合可能改善患者管理,并可能有助于鉴别其他肾脏肿瘤。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To test the feasibility of two-dimensional fast Fourier transforms (FFT)-based imaging metrics in differentiating solid, non-macroscopic fat containing, enhancing renal masses using contrast-enhanced CT images. We quantify image-based intratumoral textural variations (indicator of tumor heterogeneity) using frequency-based (FFT) imaging metrics.
METHODS: In this Institutional Review Board approved, Health Insurance Portability and Accountability Act -compliant, retrospective case-control study, we evaluated 156 patients with predominantly solid, non-macroscopic fat containing, enhancing renal masses identified between June 2009 and June 2016. 110 cases (70%) were malignant RCC, including clear cell, papillary and chromophobe subtypes and, 46 cases (30%) were benign renal masses: oncocytoma and lipid-poor angiomyolipoma. Whole lesions were manually segmented using Synapse 3D (Fujifilm, CT) and co-registered from the multiphase CT acquisitions for each tumor. Pathological diagnosis of all tumors was obtained following surgical resection. Matlab function, FFT2 was used to perform the image to frequency transformation.
RESULTS: A Wilcoxon rank sum test showed that FFT-based metrics were significantly (p < 0.005) different between 1. benign vs malignant renal masses, 2. oncocytoma vs clear cell renal cell carcinoma and 3. oncocytoma vs lipid-poor angiomyolipoma. Receiver operator characteristics analysis revealed reasonable discrimination (area under the curve >0.7, p < 0.05) within these three groups of comparisons.
CONCLUSION: In combination with other metrics, FFT-metrics may improve patient management and potentially help differentiate other renal tumors. Advances in knowledge: We report for the first time that FFT-based metrics can differentiate between some solid, non-macroscopic fat containing, enhancing renal masses using their contrast-enhanced CT data.
引用
- Varghese BA, Chen F, Hwang DH, et al. Differentiating solid, non-macroscopic fat containing, enhancing renal masses using fast Fourier transform analysis of multiphase CT. Br J Radiol. 2018. PMID: 29888982. doi:10.1259/bjr.20170789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。